Literature DB >> 8878519

A species comparison of chloral hydrate metabolism in blood and liver.

J C Lipscomb1, D A Mahle, W T Brashear, C M Garrett.   

Abstract

Chloral hydrate (CH), [302-17-0], is a human sedative useful in premature infants. No current epidemiological study supports increased cancer risk. CH is also a rodent toxicant and a P450-derived metabolite of trichloroethylene (TRI). P450 induction increases TRI toxicity in rodents. CH is very rapidly metabolized to trichloroacetic acid (TCA) and trichloroethanol (TCOH). Because TCA mediates some responses following TRI exposure, we assessed the metabolism of CH to TCA and TCOH by liver and blood of the rat, mouse, and human. Both TCA and TCOH are formed in blood and liver. The constants for hepatic TCA and TCOH formation are presented. The K(m) for hepatic TCOH formation is at least ten-fold lower than for TCA formation in these species. Clearance values for TCOH are higher than for TCA. These data support TCOH as the first major metabolite of TRI and CH in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878519     DOI: 10.1006/bbrc.1996.1511

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: liver effects.

Authors:  Hong Sik Yoo; Blair U Bradford; Oksana Kosyk; Svitlana Shymonyak; Takeki Uehara; Leonard B Collins; Wanda M Bodnar; Louise M Ball; Avram Gold; Ivan Rusyn
Journal:  J Toxicol Environ Health A       Date:  2015

2.  Lack of formic acid production in rat hepatocytes and human renal proximal tubule cells exposed to chloral hydrate or trichloroacetic acid.

Authors:  Edward A Lock; Celia J Reed; Joellyn M McMillan; John E Oatis; Rick G Schnellmann
Journal:  Toxicology       Date:  2006-11-18       Impact factor: 4.221

Review 3.  Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity.

Authors:  Lawrence H Lash; Weihsueh A Chiu; Kathryn Z Guyton; Ivan Rusyn
Journal:  Mutat Res Rev Mutat Res       Date:  2014 Oct-Dec       Impact factor: 5.657

4.  Evaluation of maternal and embryotoxic effects following the treatment of chloral hydrate in Drosophila melanogaster.

Authors:  Arif Ayar; Deniz Altun Çolak; Handan Uysal
Journal:  Cytotechnology       Date:  2014-08-07       Impact factor: 2.058

5.  Xenobiotic exposure and autoimmune hepatitis.

Authors:  Kathleen M Gilbert
Journal:  Hepat Res Treat       Date:  2010-12-30

6.  Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol.

Authors:  Apryl Bronley-DeLancey; David C McMillan; JoEllyn M McMillan; David J Jollow; Lawrence C Mohr; David G Hoel
Journal:  Environ Health Perspect       Date:  2006-08       Impact factor: 9.031

Review 7.  Human variability and susceptibility to trichloroethylene.

Authors:  G M Pastino; W Y Yap; M Carroquino
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 8.  Metabolism of trichloroethylene.

Authors:  L H Lash; J W Fisher; J C Lipscomb; J C Parker
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 9.  Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease.

Authors:  Glinda S Cooper; Kathleen M Gilbert; Eric L Greidinger; Judith A James; Jean C Pfau; Leslie Reinlib; Bruce C Richardson; Noel R Rose
Journal:  Environ Health Perspect       Date:  2008-06       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.